期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
产葡萄糖异构酶细胞的固定化 被引量:5
1
作者 邓辉 陈晟 +1 位作者 陈坚 吴敬 《食品科学》 EI CAS CSCD 北大核心 2013年第9期164-169,共6页
采用壳聚糖絮凝和戊二醛交联的方法,对表达生产Thermobifida fusca葡萄糖异构酶(GIase)的重组大肠杆菌细胞进行固定化工艺研究,以期获得高性能和低成本的固定化产酶细胞方法。考察影响细胞絮凝和交联的各种因素,并对固定化酶制剂的理化... 采用壳聚糖絮凝和戊二醛交联的方法,对表达生产Thermobifida fusca葡萄糖异构酶(GIase)的重组大肠杆菌细胞进行固定化工艺研究,以期获得高性能和低成本的固定化产酶细胞方法。考察影响细胞絮凝和交联的各种因素,并对固定化酶制剂的理化性质、动力学常数进行测定。结果表明:最佳的固定化条件为在高密度发酵液中添加0.6%硅藻土和5mmol/L Mg2+,经60℃热处理30min后,在壳聚糖终质量分数0.1‰、pH5.5、充分搅拌条件下絮凝,酶活回收率达98%;絮凝产物在戊二醛体积分数0.25%、pH6.5、轻微搅拌条件下交联3h,以未交联的样品作参照(100%),交联样品的酶活保留率达80%。相对于游离GIase,此条件下制备的固定化GIase的最适温度仍为80℃、最适pH值从10降低至9;在工业生产应用条件下,固定化GIase的初始酶活力达到356U/g,半衰期为61d,能够满足高果糖浆工业的生产要求。 展开更多
关键词 葡萄糖异构酶 重组大肠杆菌细胞 固定化 壳聚糖絮凝 戊二醛交联
下载PDF
Simultaneous Expression of Vitreoscilla Globin Gene and Lytic Genes of Phage A in a Novel Recombinant Escherichia Coli Used for Production of PHB 被引量:2
2
作者 于慧敏 史悦 +2 位作者 尹进 沈忠耀 杨胜利 《Chinese Journal of Chemical Engineering》 SCIE EI CAS CSCD 2001年第4期407-411,共5页
Exogenous Vitreoscilla globin gene (vgb), lytic genes of phage A with S amber mutation (S-RRz) and poly(B-hydroxybutyrate) (PHB) biosynthetic genes (phbCAB) were cloned into a same Escherichia coli cell, simultaneousl... Exogenous Vitreoscilla globin gene (vgb), lytic genes of phage A with S amber mutation (S-RRz) and poly(B-hydroxybutyrate) (PHB) biosynthetic genes (phbCAB) were cloned into a same Escherichia coli cell, simultaneously or respectively. Six novel strains containing phbCAB and vgb with or without lytic genes were constructed. Strain VG1 (pTU14), in which vgb, phbCAB and S-RRz could all be successfully expressed, has superior characteristics in cell growth and PHB accumulation, while the results of strains containing vgb and phbCAB without S- RRz were not better than that of strains harbored ph&CAB only. The simultaneous expression of vgb and S- RRz in the recombinant VG1 (pTU14) showed a great potential for low-cost production of PHB. 展开更多
关键词 Vitreoscilla hemoglobin lytic genes of phage λ poly (β-hydroxybutyrate)
下载PDF
Permeabilization of Escherichia coli with ampicillin for a whole cell biocatalyst with enhanced glutamate decarboxylase activity 被引量:2
3
作者 Weirui Zhao Sheng Hu +5 位作者 Jun Huang Piyu Ke Shanjing Yao Yinlin Lei Lehe Mei Jinbo Wang 《Chinese Journal of Chemical Engineering》 SCIE EI CAS CSCD 2016年第7期909-913,共5页
The activity of whole-cell biocatalysts is strongly compromised by the cell envelope, which is a permeability harrier against the diffusion of substrates and products. Although common chemical or physical permeahiliza... The activity of whole-cell biocatalysts is strongly compromised by the cell envelope, which is a permeability harrier against the diffusion of substrates and products. Although common chemical or physical permeahilization methods used in cultured cells enhance cell permeability, these methods inevitably add several extra processing steps after cell cultivation, as well as impede large scale processing. To increase membrane permeability and cell- bound glutamate decarboxylase (GAD) activity of recombinant Escherichia coil (BL21 (DE3)-pET28a-gadB) cells without the need for an additional permeabilization step, we investigated the permeabilizing effects of adding cell wall synthesis inhibitors or suffactants to the culture media. Ampidllin was the most effective at improving cell-bound GAD activity of the BL21 (DE3)-pET28a-gadB, although it decreased the cell biomass yield. The best permeabilization effect was observed using an ampicillin concentration of 5 pg. ml-1. Using this concentration, the cell hiomass did decrease by 40.58%, but the cell-bound GAD activity of BL21 (DE3)-pET28a-gadB and total cell-bound GAD activity per milliliter of culture was enhanced by 6.24- and 3.64-fold, respectively. Treatment ofBL21 (DE3)-pET28a-gadB cells with 5 tag.ml 1 ampicillin resulted in structural changes to the cell envelope, but did not substantially affect GAD expression. By entrapping the ampicillin-treated cells in an open pore gelation matrix, which is a polymer derived from polyvinyl alcohol (PVA), alginate, and boric acid, the transfor- mation rate of γ-aminobutyric acid (GABA) at the 10th cycle produced by immobilized and permeabilized cells remained 46% of the first cycle. GAD activity of the immobilized, permeabilized cells remained over 90% after 30 days of storage at 4 ℃. 展开更多
关键词 γ-Aminobutyric acidAmpicillinEscherichio. coilGlutamate decarboxylasePermeabilization
下载PDF
Biosynthesis of(R)-2-hydroxy-3-phenylpropionic acid using whole recombinant Escherichia coli cells in an aqueous/n-octane biphasic system
4
作者 Yi-bo ZHU Yan XU +1 位作者 Li-mei WANG Bin QI 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2018年第4期285-292,共8页
(R)-2-hydroxy-3-phenylpropionic acid (PIP,) is an ideal antimicrobial compound with broad-spectrum activity against a wide range of Gram-positive bacteria, some Gram-negative bacteria, and fungi. We studied the bi... (R)-2-hydroxy-3-phenylpropionic acid (PIP,) is an ideal antimicrobial compound with broad-spectrum activity against a wide range of Gram-positive bacteria, some Gram-negative bacteria, and fungi. We studied the bioconversion of phenylpyruvate (PPA) to PLA using whole recombinant Escherichia coli cells in a series of buffer/organic solvent systems. Octane was found to be the best organic solvent. The optimum volume ratio of the water phase to the n-octane phase, conversion temperature, substrate concentration, and cell concentration were 6:4, 40 ℃, 12.5 g/L, and 30 g/L wet cells, respectively. Under the optimized conditions, the average PLA productivity in the aqueous/ n-octane system was 30.69% higher than that in the aqueous system, and 32.31 g/L PLA was obtained with the use of a stirred reactor (2-L scale). Taken together, our findings indicated that PLA biosynthesis was more efficient in an aqueous/n-octane biphasic system than in a monophasic aqueous system. The proposed biphasic system is an effective strategy for enhancing PLA yield and the biosynthesis of its analogues. 展开更多
关键词 (R)-2-hydroxy-3-phenylpropionic acid Phenylpyruvate Aqueous/n-octane biphasic system Whole cell bioconversion Recombinant Eschenchia coli
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部